Introduction: Obesity can be divided into metabolic syndrome (MetS) or metabolically unhealthy obesity (MUO) and metabolically healthy obesity (MHO). In the current scenario, with researches nearing a definition for MHO, it becomes crucial to establish the risks of associated comorbidities of obesity in its subtypes, namely MHO and MetS. With PCOS being generally associated with obesity and an increased risk of cardiovascular diseases, research must be done to determine its relation with MHO and MetS. Objectives: Therefore, the purpose of this study is to investigate and compare the key anthropometric and metabolic frameworks of women having PCOS in obese phenotypes, namely, MHO and MetS/MUO in the reproductive age group. Results: The clinical attributes and metabolic aspects in women having polycystic ovarian syndrome with MHO will be significantly different than those found in PCOS with MetS/MUO in the reproductive age group. Conclusion: The clinical and metabolic aspects of women with MHO as study group will be different in PCO women with or without MetS/MUO and may have more risk of development of the cardiovascular disease.